Clinical Trials · NCT02607293
A Study to Explore Correlation Between Symptoms and Signs of Polycystic Ovarian Syndrome (PCOS) and Risk of Over-response to Ovarian Stimulation
- Phase
- N/A
- Recruitment status
- Completed
- Sponsor
- Merck KGaA, Darmstadt, Germany
- Enrollment
- 1,064
- Start date
- Dec 2015
- Locations
- 1 site, Germany
- Primary endpoint
- Number of subjects with polycystic ovary